The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index; 140 of the 341 sources its claims cite were checked for support.
Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology
Open accessAbstract
According to the free hormone hypothesis, biological activity of a certain hormone is best reflected by free rather than total hormone concentrations. A crucial element in this theory is the presence of binding proteins, which function as gatekeepers for steroid action. For testosterone, tissue exposure is governed by a delicate equilibrium between free and total testosterone which is determined through interaction with the binding proteins sex hormone-binding globulin and albumin. Ageing, genetics and various pathological conditions influence this equilibrium, hereby possibly modulating hormonal exposure to the target tissues. Despite ongoing controversy on the subject, strong evidence from recent in vitro, in vivo and human experiments emphasizes the relevance of free testosterone. Currently, however, clinical possibilities for free hormone diagnostics are limited. Direct immunoassays are inaccurate, while gold standard liquid chromatography with tandem mass spectrometry (LC-MS/MS) coupled equilibrium dialysis is not available for clinical routine. Calculation models for free testosterone, despite intrinsic limitations, provide a suitable alternative, of which the Vermeulen calculator is currently the preferred method. Calculated free testosterone is indeed associated with bone health, frailty and other clinical endpoints. Moreover, the added value of free testosterone in the clinical diagnosis of male hypogonadism is clearly evident. In suspected hypogonadal men in whom bo…
Overview
CoChat Summary
TL;DR
This review argues that free testosterone better reflects androgen action than total testosterone and should be integrated into the diagnostic workflow for male hypogonadism, especially when total testosterone is borderline low or SHBG is altered. It synthesizes in vitro, in vivo, and human evidence while acknowledging that direct free testosterone measurement is not routine and that calculated free testosterone has methodological limitations.
Key findings
- In vitro and in vivo data support the free hormone hypothesis: SHBG inhibits androgen bioactivity, and SHBG transgenic mice had approximately 200-fold higher total testosterone and DHT than wildtype mice but free testosterone was not different; LH was significantly higher, and androgen-sensitive organ weights were reduced.
- Human cases support free hormone activity: a male with unmeasurably low SHBG had extremely low total testosterone but normal free testosterone, and a patient with undetectable DBP had low total 25(OH)D and 1,25(OH)₂D but normal free fractions.
- In >300 human serum samples, median calculated-to-measured free testosterone ratios were 1.19 for Vermeulen, 1.0 for Ly/Handelsman, and 2.05 for Zakharov; the Vermeulen formula overestimated free testosterone by 20–30% but was independent of SHBG, total testosterone, and albumin.
- In the EMAS cohort of 3334 men, using total testosterone alone gave false-positive and false-negative findings of 23.1% and 9.5%, respectively; only 27.3% of men with low total testosterone truly had low free testosterone. In another cohort of 3672 men, 61.7% of subjects with decreased total testosterone had normal calculated free testosterone.
Methods
- Design: narrative review, not a systematic review or meta-analysis; the authors performed a literature search and synthesized evidence on the free hormone hypothesis, SHBG biology, free testosterone methodology, and clinical associations.
- Evidence base: includes in vitro HEK-293 androgen receptor reporter assays, SHBG transgenic mouse models, human case reports, and cohort studies such as EMAS (3334 men), a Belgian consortium dataset (>300 serum samples), and a 3672-man cohort.
- Analysis: qualitative synthesis of published and authors’ group data; no new primary randomized or prospective trial data are reported.
Limitations
- Stated: no prospective studies have been conducted on SHBG associations, so causation cannot be established; most SHBG associations are cross-sectional.
- Stated: free testosterone calculators have intrinsic limitations, including dependence on SHBG/total testosterone assay quality, different binding-affinity and stoichiometry assumptions, method-specific reference ranges, and no universal cut-off; direct LC–MS/MS coupled equilibrium dialysis is labor-intensive, costly, and not routinely available.
- Evident from the text: clinical endpoint evidence largely relies on calculated rather than directly measured free testosterone, and the review is narrative rather than systematic, so selection and heterogeneity across cited studies are not formally assessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
112 Valid · 3 Not valid · 103 Not checked · 69 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Binding site competition and allosteric coupling can in certain conditions, especially postprandial and in circumstances of heightened levels of fatty acids and drug usage, result in displacement of T from its binding site thereby potentially affecting T bioavailability and/or metabolism [25, 26].”
What the sources say
- Partly supportedcites [25] Jayaraj A, Schwanz HA, Spencer DJ, Bhasin S, Hamilton JA, Jayaram B et al (2021) Allosterically coupled multisite binding of testosterone to human serum albumin. Endocrinology. https://doi.org/10.1210/endocr/bqaa199 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [26] Czub MP, Venkataramany BS, Majorek KA, Handing KB, Porebski PJ, Beeram SR et al (2019) Testosterone meets albumin - the molecular mechanism of sex hormone transport by serum albumins. Chem Sci 10(6):1607–1618. https://doi.org/10.1039/c8sc04397c sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Hence, the sum of the free and the albumin-bound fraction was determined to constitute the biological available (or bioavailable) amount in circulation (Fig. 1).”
What the sources say
- Supportedcites [21] Chen Z, Shen X, Tian K, Liu Y, Xiong S, Yu Q et al (2020) Bioavailable testosterone is associated with symptoms of depression in adult men. J Int Med Res 48(8):300060520941715. https://doi.org/10.1177/0300060520941715 source
The Introduction (page not available in our copy) identifies free, albumin-bound, and SHBG-bound testosterone as circulating fractions and says SHBG-bound testosterone loses its biological activity. This supports the cited description of the free and albumin-bound fractions as bioavailable testosterone, although the paper does not state the sum explicitly. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [22] Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 84(2):573–577. https://doi.org/10.1210/jcem.84.2.5495 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, genetic variation in SHBG also alters the binding affinity constant for T and DHT [42].”
What the sources say
- Supportedcites [42] Wu TS, Hammond GL (2014) Naturally occurring mutants inform SHBG structure and function. Mol Endocrinol 28(7):1026–1038. https://doi.org/10.1210/me.2014-1058 source
The mutant-property passage reports that naturally occurring SHBG variants T48I and R123H have reduced affinity for both DHT and testosterone. The steroid-binding capacity methods passage says the study determined affinity constants for wild-type and mutant SHBG. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While not applicable to T and SHBG, megalin- and cubilin-mediated endocytosis is, however, relevant in vitamin D metabolism. Being mainly expressed on the luminal brush border membrane of the renal proximal convoluted tubule, megalin and cubilin bind and reabsorb the vitamin D–DBP complex from the glomerular ultrafiltrate, hereby preventing uncontrolled loss of vitamin D metabolites in urine.”
What the sources say
- Not checked — no full text of the sourcecites [36] Kaseda R, Hosojima M, Sato H, Saito A (2011) Role of megalin and cubilin in the metabolism of vitamin D(3). Ther Apher Dial 15(Suppl 1):14–17. https://doi.org/10.1111/j.1744-9987.2011.00920.x source
- Supportedcites [37] Bouillon R, Schuit F, Antonio L, Rastinejad F (2019) Vitamin D binding protein: a historic overview. Front Endocrinol (Lausanne) 10:910. https://doi.org/10.3389/fendo.2019.00910 source
The “DBP Binds to Megalin-Cubilin Receptor” section says both receptors are expressed mainly at the luminal brush border of the renal tubuli and that the receptor complex internalizes DBP bound to 25OHD. “Summary and Perspectives” states that they reabsorb the complex after glomerular filtration, preventing urinary loss. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For the second SNP, rs6258, a rare missense polymorphism located in exon 4 of SHBG, lower concentrations of T were observed for the CT vs CC genotype.”
What the sources say
- Supportedcites [65] Ohlsson C, Wallaschofski H, Lunetta KL, Stolk L, Perry JR, Koster A et al (2011) Genetic determinants of serum testosterone concentrations in men. PLoS Genet 7(10):e1002313. https://doi.org/10.1371/journal.pgen.1002313 source
Table 2 (Results; page not provided) reports lower serum testosterone for the rs6258 CT genotype than for CC in the EMAS replication cohort (358 versus 474 ng/dl). The Results also identify rs6258 as a non-synonymous variant in exon 4 of SHBG; the genotype counts are consistent with it being rare. (LLM, conf=0.94)
- Partly supportedcites [66] Grigorova M, Punab M, Poolamets O, Adler M, Vihljajev V, Laan M (2017) Genetics of sex hormone-binding globulin and testosterone levels in fertile and infertile men of reproductive age. J Endocr Soc 1(6):560–576. https://doi.org/10.1210/js.2017-00050 sourceExperimental — accuracy not yet measured
Results §2.C identifies rs6258 as a rare C>T missense variant in SHBG and reports substantially lower total testosterone in heterozygous carriers than in wild-type carriers, supporting the CT-versus-CC comparison. Our copy does not specify that rs6258 is in exon 4 (page numbers unavailable). (LLM, conf=0.88)
- Partly supportedcites [67] Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimaki T, Keildson S et al (2012) A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet 8(7):e1002805. https://doi.org/10.1371/journal.pgen.1002805 sourceExperimental — accuracy not yet measured
The Discussion identifies rs6258 as a missense variant, and Results Table 2 shows that its T allele is uncommon and associated with lower SHBG concentrations. The paper does not report lower testosterone (T) concentrations for CT versus CC carriers or specify that rs6258 is in exon 4; the reported outcome is SHBG, not testosterone. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
131 more claims · 50 with their cited sources checked
Create a free account to see all 287 claims and every source verdict.
- It may state two separate claims as one. 104
- Probably not a substantial claim. 74
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Introduction
“As no prospective studies have been conducted, statements on causation are lacking.”
§ Introduction
“In a large longitudinal cohort study, lower SHBG was an independent risk factor for the development of T2D, inferring a five- or ninefold higher risk for male and female subjects, respectively, as compared to the reference group, hereby confirming findings from smaller studies [117–119].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Introduction
“In contrast, in female patients with anorexia nervosa, SHBG concentrations were lower compared to normal weight subjects and increased to normal range after adequate weight gain, thus being a reliable index of nutritional status [93].”
§ Introduction
“Conditions associated with alterations in SHBG concentrations Increased SHBG Decreased SHBG Aging Obesity Thyrotoxicosis Type 2 diabetes mellitus Liver disease (e.g., cirrhosis, hepatitis) Hypothyroidism HIV infection Nephrotic syndrome Anti-convulsants Increase in growth hormone and acromegaly Therapeutic drugs with estrogenic properties (e.g., combined oral contraceptives) Therapeutic drugs with androgenic/progestagenic properties”
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 5×
“Addition of a tracer element, 3H-testosterone, to the sample or direct measurement by immunoassay or LC–MS/ MS, allows for assessment of both the free and albuminbound fraction in the supernatant [208, 210].”
BackgroundMethodInfluentialAll About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 1×
“Hence, structurally, each type of steroid hormone is based on the classic cyclopentanophenanthrene four-ring structure, or a derivative [2].”
BackgroundMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736 · cited 6×
“Furthermore, in accordance with ES guidelines, added value of free T is also evident when SHBG levels are altered [7].”
BackgroundMethodInfluentialIdentification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238
Research works printed but not linked: 2
- Sahu P, Pinkalwar N, Dubey R, Paroha S, Chatterjee S, Chatterjee T (2011) Biomarkers: an emerging tool for diagnosis of a disease and drug development. Asian J Res Pharm Sci 1:9–16
- Winters SJ (2020) Laboratory Assessment of Testicular Function. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905368.
Cited by
Testosterone and Male Bone Health: A Puzzle of Interactions
Tenuta, M., Hasenmajer, V., Gianfrilli, D., & Isidori, A. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf191 · Cited by 43
Salvio, G., Ciarloni, A., Ambo, N., Bordoni, M., Perrone, M., Rossi, S., & Balercia, G. (2025) · Andrology · doi:10.1111/andr.70022 · Cited by 41
Steroid hormone levels vary with sex, aging, lifestyle, and genetics
Deltourbe, L. G., Sugrue, J. A., Maloney, E., Dubois, F., Jaquaniello, A., Bergstedt, J., Patin, É., Quintana‐Murci, L., Ingersoll, M. A., & Duffy, D. (2025) · Science Advances · doi:10.1126/sciadv.adu6094 · Cited by 33
Male-specific consequences of obesity — functional hypogonadism and fertility disorders
Rabijewski, M. (2023) · Endokrynologia Polska · doi:10.5603/ep.95626 · Cited by 27
“Also, the incidence of FH was investigated in the population of Polish obese, diabetic men [19].”
BackgroundEstrogen: the forgotten player in metaflammation
Zhu, B. T., Liao, Q.-Q., Tian, H., Yu, D., Xie, T., Sun, X., Zhou, X.-M., Han, Y., Zhao, Y., El‐Kassas, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1478819 · Cited by 22
Metadata
- Authors
- Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Ghent University (BE)
- KU Leuven (BE)
- Ghent University Hospital (BE)
- Corresponding author
- Vanderschueren, D.
- ORCID
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2022-10-07
- Volume
- 79
- Issue
- 11
- Pages
- 543-543
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11803068
- OpenAlex
- W4303419200
- Cited by
- 96
- References
- 260
- Citations by year
- 2026: 26 · 2025: 33 · 2024: 24 · 2023: 12 · 2022: 1
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Funders
- Flanders Research Foundation (T004321N)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- sex hormone-binding globulin, free testosterone, free hormone hypothesis, albumin, testosterone replacement therapy, bone health, frailty, aging
- MeSH terms
- Albumins, Androgens, Chromatography, Liquid, Humans, Hypogonadism, Male, Sex Hormone-Binding Globulin, Testosterone, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. https://app.cochat.ai/papers/10.1007/s00018-022-04562-1
- The paper
- Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022). Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-022-04562-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.